All articles by Mrinmoyee Hazarika

  1. Exicure adds new sites to Phase Ib/II trial of AST-008

    Exicure has added four new clinical trial sites for its Phase Ib/II trial of AST-008 for the treatment of various…
    Read More…

    7 Feb
  2. Spero receives US FDA approval for Phase III trial of SPR994

    Spero Therapeutics has received approval from the US Food and Drug Administration (FDA) to begin a Phase III clinical trial…
    Read More…

    6 Feb
  3. Neurana enrols first patient in Phase II trial of tolperisone

    Neurana Pharmaceuticals has enrolled the first patient in the Phase II STAR Study evaluating tolperisone for the treatment of acute…
    Read More…

    6 Feb
  4. uniQure treats first patient in HOPE-B trial for hemophilia B

    uniQure has treated the first patient in the HOPE-B trial evaluating AMT-061 for the treatment of patients with hemophilia B….
    Read More…

    6 Feb
  5. Verseon starts dosing in trial of VE-1902 to treat CAD

    Verseon has started dosing in a Phase I clinical trial evaluating VE-1902 for the prevention of stroke and heart attack…
    Read More…

    5 Feb
  6. Eli Lilly reports positive data from atopic dermatitis trials

    Eli Lilly and Company and its study partner Incyte has reported positive top-line results from the Phase III BREEZE-AD1 and BREEZE-AD2…
    Read More…

    5 Feb
  7. Actinium starts dosing second cohort in trial of Actimab-A and CLAG-M

    Actinium Pharmaceuticals has started dosing patients in the second cohort of its Phase I trial studying Actimab-A in combination with…
    Read More…

    5 Feb
  8. Okogen starts Phase II OKG-0301 trial for adenoviral conjunctivitis

    Okogen has commenced the Phase II RUBY clinical trial to investigate the safety and efficacy of OKG-0301 for the treatment…
    Read More…

    4 Feb
  9. DrugCendR reports positive data from pancreatic cancer trial

    DrugCendR has reported positive early results from its ongoing Phase I clinical trial evaluating CEND-1 in combination with nabpaclitaxel and…
    Read More…

    4 Feb
  10. Newron completes enrolment in STARS trial for apneas in Rett syndrome

    Newron Pharmaceuticals has completed patient enrolment in the pivotal Sarizotan for the Treatment of Apneas in Rett Syndrome (STARS) clinical…
    Read More…

    4 Feb
Close
Close
Close

Go Top